Yahoo Web Search

  1. Ad
    related to Amgen Inc
  1. So shareholders might well want to know whether insiders have been buying or selling shares in Amgen Inc. (NASDAQ:AMGN). It is perfectly legal for company insiders, including board ...

  2. Is Amgen, Inc. (AMGN) A Good Stock To Buy According To Hedge Funds?

    Insider Monkey via Yahoo FinanceOct 09 20:46 PM

    Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. A particularly interesting group of stocks ...

  3. Pfenex Gets FDA Seal of Approval For Amgen's Forteo Biosimilar

    Benzinga via Yahoo FinanceOct 07 14:36 PM

    Shares of the micro-cap biotech Pfenex Inc (NYSE: PFNX), which pulled back ahead of the PDUFA date for its Forteo biosimilar PF708, were advancing Monday amid a positive outcome for the ...

  4. Amgen (AMGN) Stock Moves -0.23%: What You Should Know

    Zacks via Yahoo FinanceSep 27 21:50 PM

    In that same time, the Medical sector lost 0.4%, while the S&P 500 gained 3.59%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $5.63 billion, down 4.63% from ...

  5. This has lagged the Medical sector's loss of 3.82% and the S&P 500's loss of 1.07% in that time. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

  6. After 500% Surge, Mirati’s Day of Reckoning Is Approaching

    Bloomberg via Yahoo FinanceOct 07 10:00 AM

    Amgen’s AMG 510 spurred a partial response in a handful of lung cancer patients, though the disease returned after a few months in some of them. Mirati investors have to ask if the disappointing ...

  7. Top Ranked Income Stocks to Buy for October 2nd

    Zacks via Yahoo FinanceOct 02 11:34 AM

    Buckle, Inc. (The) Dividend Yield (TTM) Buckle, Inc. (The) dividend-yield-ttm | Buckle, Inc. (The) Quote Amgen Inc. (AMGN): This developer and manufacturer ...

  8. An experimental Amgen Inc drug that targets a specific genetic mutation shrank tumors in just one of 12 patients with advanced colorectal cancer who were given the highest dose ...

  9. This weekend's Barron's cover story offers 15 roundtable biotech stock picks. Other featured articles discuss the state of the IPO market and dividend-paying value picks. Also, the prospects ...

  10. For the last reported quarter, Amgen came out with earnings of $3.97 per share versus the Zacks Consensus Estimate of $3.58 per share, representing a surprise of 10.89%. With this earnings ...

  1. Ads
    related to Amgen Inc